Causes of High HbA1c With Normal Blood Glucose
A high HbA1c alongside normal-looking glucose usually means one of three things. The assay is being fooled by something in your blood, your red cells are living longer than average so their hemoglobin accumulates more glucose, or your glucose is not as normal as your sampling suggests. HbA1c measures the fraction of hemoglobin that has been non-enzymatically glycated, and that fraction depends on both the glucose the cell saw and how long the cell has been alive. Any variable that touches red cell lifespan or the measurement chemistry moves the number without moving your glycemia. The distinction matters because the workup for each is different, and only a clinician can act on the answer.
Two different failures hide behind the same number
It helps to separate analytical interference from biological discordance. Analytical interference means the instrument reported the wrong glycated fraction. Biological discordance means the glycated fraction is correct but does not reflect your average glucose, because the red cell population itself is unusual. Both kinds are reviewed together in the clinical literature on misleading HbA1c results, and they call for different confirmatory tests 12.
Start by knowing your average glucose independently. The ADAG relationship gives estimated average glucose as 28.7 × HbA1c − 46.7 mg/dL, so an HbA1c of 6.2% predicts roughly 131 mg/dL. If two weeks of continuous glucose monitoring puts your mean at 100 mg/dL, the gap is real and worth explaining.
What falsely elevates the assay
Interference depends on which method your lab runs, so the first question to ask is what platform produced the result. Cation-exchange HPLC separates hemoglobin species by charge. Anything that changes the charge of hemoglobin can co-elute with the HbA1c peak. Carbamylated hemoglobin in uremia and acetylated hemoglobin from very high salicylate exposure are the classic examples 1.
Immunoassays recognize the glycated N-terminus of the beta chain. Hemoglobin variants that alter that region, or that shift the proportion of beta chains available, can bias the result in either direction. Elevated fetal hemoglobin above roughly 10 to 15% is a common cause of a spurious reading, since HbF lacks the beta-chain epitope entirely 1. Boronate affinity chromatography binds cis-diol groups on glucose and is comparatively tolerant of variants, which is why it is the sensible fallback when a variant is suspected.
Other reported analytical confounders include severe hypertriglyceridemia, marked hyperbilirubinemia, and high-dose vitamin C or vitamin E 3. These are laboratory-specific. A single call to the lab asking for the method and whether the chromatogram showed an abnormal peak resolves more cases than any additional blood draw.
When the assay is right and the red cells are the problem
If the chemistry is clean, look at red cell turnover. Longer-lived erythrocytes accumulate more glycation at the same glucose, so anything that slows turnover raises HbA1c. Iron deficiency is the most common example, and correcting it typically lowers HbA1c without any change in glycemia 34. Vitamin B12 and folate deficiency behave similarly. Splenectomy also removes a major site of red cell clearance.
The reverse also exists and produces falsely low values. The causes are listed below.35
- hemolysis
- recent transfusion
- blood loss
- chronic kidney disease with shortened cell survival
- erythropoietin therapy
- late pregnancy
Reticulocytosis of any cause dilutes the glycated pool with young cells.
There is also a persistent, reproducible person-level offset that is not explained by any of the above. Two people with identical mean glucose can differ by several tenths of a percentage point in HbA1c, and that offset is stable over time. It tracks partly with ancestry, with higher HbA1c at a given glycemia reported in Black compared with White participants in controlled studies 6. It likely reflects heritable variation in red cell lifespan and in the intracellular glucose gradient across the erythrocyte membrane 5. Genome-wide methylation studies have also identified CpG sites associated with HbA1c, which is consistent with regulatory variation contributing to the biomarker independently of glucose 7.
Confirming the mismatch with your own data
The measurement you need is your mean glucose over the same window the HbA1c integrates, which is roughly the preceding 8 to 12 weeks weighted toward the last 4. Fingersticks will not do this, because they undersample postprandial excursions and overweight fasting values. Sampling that way is exactly the pattern that makes a real glucose elevation look normal.
Use a continuous glucose monitor for at least 14 days and require at least 70% sensor capture before you trust the summary. Export the raw CSV from Dexcom Clarity or LibreView, parse the timestamp and glucose columns, and compute the arithmetic mean over valid readings. Then compute the glucose management indicator:
gmi = 3.31 + 0.02392 * df["glucose_mg_dl"].mean()
GMI is what your HbA1c would be if you sat at the population-average relationship. The difference between your lab HbA1c and your GMI is the quantity of interest. Interpret it with the sensor’s error in mind. A CGM with a mean absolute relative difference near 9% can carry a systematic bias of several mg/dL, and a 10 mg/dL bias shifts GMI by 0.24 percentage points. Treat gaps under about 0.3 points as noise. Gaps above 0.5 points, reproduced on a second sensor, are real.
Then get an orthogonal glycation marker that does not involve hemoglobin. Fructosamine measures total glycated serum protein and glycated albumin measures the albumin fraction specifically, both reflecting roughly the preceding two to three weeks 8. If HbA1c is high while glycated albumin and CGM-derived GMI both sit in the normal range, the problem is in the hemoglobin compartment. If all three are elevated, your glucose is elevated and the HbA1c is telling the truth 9.
A practical panel to bring to a clinician alongside the CGM export is listed below.
- complete blood count with reticulocyte count and red cell indices
- ferritin with transferrin saturation
- B12 and folate
- LDH
- haptoglobin
- bilirubin
- creatinine with eGFR
- hemoglobin variant analysis by HPLC or capillary electrophoresis
Reading your genome for red cell causes
Whole-genome sequencing answers several of these questions without a blood draw, provided you know what the pipeline does and does not call.
Coding variants in HBB are straightforward. The sickle allele rs334 (Glu6Val) is a single base substitution that any standard GATK or DeepVariant callset will report from a BAM or CRAM aligned to GRCh38. Beta-thalassemia alleles and HbE fall out the same way. Variants in the red cell membrane genes SPTA1, SPTB, ANK1, and SLC4A1 are worth inspecting because they shorten cell survival and lower HbA1c. G6PD and PKLR variants act the same direction.
Alpha-globin is the failure mode to watch. The common alpha-thalassemia alleles are deletions, most often the 3.7 kb rightward deletion, and SNV callers will not see them. You need copy number from read depth across chr16:170,000-180,000, and that region is GC-rich with poor coverage uniformity on PCR-based library preps. Use a PCR-free library, normalize depth against a matched-GC background, and treat a single-sample CNV call there as a hypothesis rather than a result. Hereditary persistence of fetal hemoglobin, which raises HbF and interferes with several assays, also involves deletions and regulatory variants in the HBB cluster that short-read pipelines call unreliably.
None of these findings is self-interpreting. A variant call is a hypothesis about your red cells that a hematologist confirms with a phenotype, and any decision about diagnosis or treatment belongs with a clinician.
Questions people also ask
What can falsely elevate HbA1c? Carbamylated hemoglobin in kidney failure, elevated fetal hemoglobin, and certain hemoglobin variants depending on assay method. Severe hypertriglyceridemia, hyperbilirubinemia, and high-dose vitamin C or E can do the same. Iron, B12, and folate deficiency raise it through slowed red cell turnover rather than assay error 31.
Is it possible to have a high HbA1c without diabetes? Yes. Any condition that lengthens red cell lifespan or interferes with the measurement produces an elevated value at normal glycemia, and a stable person-level offset exists even in healthy people 65.
What is the danger zone for HbA1c? Clinical guidelines use 5.7 to 6.4% as the range flagged for elevated risk and 6.5% and above as the diagnostic threshold, confirmed on a repeat sample. Those thresholds assume the assay is valid for you, which is the whole point of the workup above, and a clinician should interpret them 4.
What is the fastest way to reduce HbA1c? HbA1c is a lagging integral of glucose, so it moves over weeks to months regardless of what you change. If the elevation comes from iron deficiency or assay interference, correcting the underlying cause changes the number without changing glucose at all. Treatment decisions belong with a physician.
Footnotes
-
Michael S. Radin. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading. Journal of General Internal Medicine, 2013. https://doi.org/10.1007/s11606-013-2595-x ↩ ↩2 ↩3 ↩4
-
Richard Hellman. When are HBA1C Values Misleading?. AACE Clinical Case Reports, 2016. https://doi.org/10.4158/ep161209.co ↩
-
Mawson Wang, Tien-Ming Hng. HbA1c: More than just a number. Australian Journal of General Practice, 2021. https://doi.org/10.31128/ajgp-03-21-5866 ↩ ↩2 ↩3 ↩4
-
Georgia Kaiafa, Stavroula Veneti, George Polychronopoulos, et al. Is HbA1c an ideal biomarker of well-controlled diabetes?. Postgraduate Medical Journal, 2020. https://doi.org/10.1136/postgradmedj-2020-138756 ↩ ↩2
-
Pichakacheri Sureshkumar, Sidharth S. Kumar, E. Anusree, et al. Navigating the discordance: a comprehensive review of HbA1c-glycemia mismatch in clinical practice. Diabetes Research and Clinical Practice, 2026. https://doi.org/10.1016/j.diabres.2026.113216 ↩ ↩2 ↩3
-
William H. Herman, Robert M. Cohen. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes. The Journal of Clinical Endocrinology & Metabolism, 2012. https://doi.org/10.1210/jc.2011-1894 ↩ ↩2
-
Eliza Walaszczyk, Mirjam Luijten, Annemieke M. W. Spijkerman, et al. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case–control sample of the Lifelines study. Diabetologia, 2017. https://doi.org/10.1007/s00125-017-4497-7 ↩
-
Maja Krhač, Marijana Vučić Lovrenčić. Update on biomarkers of glycemic control. World Journal of Diabetes, 2019. https://doi.org/10.4239/wjd.v10.i1.1 ↩
-
Timothy J. Lyons, Arpita Basu. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Translational Research, 2012. https://doi.org/10.1016/j.trsl.2012.01.009 ↩
Pothos builds longitudinal molecular profiles of individuals: whole-genome sequencing, single-cell RNA sequencing, and plasma proteomics, delivered as a detailed report, every data file, and stored cells. Build your profile.